Skip to main content
Premium Trial:

Request an Annual Quote

Immunological Data Sharing Consortium Wins €8.4M Award From EU, Canada

NEW YORK (GenomeWeb) – The newly launched iReceptor Plus Consortium has received a total of €8.4 million ($9.6 million) in awards from the European Union and the Canadian government to promote integration and sharing of human immunological data. Recipients said the funding would help researchers advance understanding of immune responses and lead to new therapeutic targets.

The four-year award will support development of a technology platform to integrate distributed repositories of Adaptive Immune Receptor Repertoire sequencing (AIRR-seq) data, which participants said would enable precision medicine and immunotherapy in cancer, inflammatory and autoimmune diseases, allergies, and infectious diseases.

"We will offer a totally new class of biomarkers to support novel treatments," iReceptor Plus Coordinator Gur Yaari, of Bar-Ilan University in Israel, said in a statement.

"Most AIRR-seq data is currently stored and curated by individual labs using a variety of tools and technologies," Yaari explained. "The platform will lower the barrier to access and analyze large AIRR-seq datasets which will ease the availability of this important data to academia, industry, and clinical partners."

The iReceptor Plus Consortium, made up of more than 20 entities from nine countries, is holding its initial conference this week in Eilat, Israel.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.